|
Orthologous residues
|
|
TBC1D1 (human): T596‑p, TBC1D1 (mouse): T590‑p, TBC1D1 iso2 (mouse): T590‑p, TBC1D1 (rat): T590‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
immunoprecipitation, mass spectrometry, mutation of modification site, phospho-antibody, western blotting
|
|
Relevant cell lines - cell types - tissues:
3T3-L1 (fibroblast), CHO (fibroblast)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
hamster, mouse
|
|
Upstream Regulation
|
|
Potential in vivo enzymes for site:
|
|
Type
|
Enzyme
|
Evidence
|
Notes
|
|
KINASE
|
Akt1 (mouse)
|
pharmacological activator of upstream enzyme, phospho-motif antibody, modification site within consensus motif
|
|
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
insulin
|
|
|
|
increase
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
phosphorylation
|
|
Comments:
p70S6K phosphorylation
|